Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Polyamine sequestration of 2′3′-cGAMP constrains intercellular transmission and STING engagement to subvert antitumor immunity
Yunjin Ma, Chunyuan Zhao, Jiacheng Guo, Yue Fu, Wei Wang, Jiangong Zhang, Kun Zhao, Xiangbo Meng, Zhongshang Yuan, Chengjiang Gao, Mutian Jia, Ying Qin, Hui Song, Wei Zhao
Yunjin Ma, Chunyuan Zhao, Jiacheng Guo, Yue Fu, Wei Wang, Jiangong Zhang, Kun Zhao, Xiangbo Meng, Zhongshang Yuan, Chengjiang Gao, Mutian Jia, Ying Qin, Hui Song, Wei Zhao
View: Text | PDF
Research Article Immunology Metabolism

Polyamine sequestration of 2′3′-cGAMP constrains intercellular transmission and STING engagement to subvert antitumor immunity

  • Text
  • PDF
Abstract

The cyclic dinucleotide 2′3′–cyclic guanosine monophosphate–adenosine monophosphate (2′3′-cGAMP) serves as a central immunotransmitter that propagates stimulator of interferon gene–dependent (STING-dependent) innate immunity across tissues; however, how microenvironmental metabolites regulate its spatiotemporal dynamics remains unknown. Here, we identified polyamines (spermine and spermidine) as critical rheostats controlling 2′3′-cGAMP functionality. Mechanistically, polyamines sequestered 2′3′-cGAMP into polymer-like aggregates, blocking intercellular propagation and suppressing intracellular STING activation by reducing ligand-receptor binding affinity. Deficiency of spermidine and spermine N1-acetyltransferase 1 (SAT1), the rate-limiting enzyme in polyamine catabolism, elevated polyamine levels to entrap extracellular 2′3′-cGAMP and inhibit STING activation. Synergistic administration of endogenous 2′3′-cGAMP with SAT1 stabilizer N1,N11-diethylnorspermine restored 2′3′-cGAMP bioavailability and STING signaling, facilitated type I interferon responses to reprogram immunologically suppressive tumors into immunologically active states and enhanced tumor clearance. Our study established polyamine–cGAMP interactions as a critical spatiotemporal regulatory mechanism for tissue-level immunity, providing a unified model for metabolite-mediated cyclic GMP-AMP synthase–STING (cGAS-STING) regulation across diseases.

Authors

Yunjin Ma, Chunyuan Zhao, Jiacheng Guo, Yue Fu, Wei Wang, Jiangong Zhang, Kun Zhao, Xiangbo Meng, Zhongshang Yuan, Chengjiang Gao, Mutian Jia, Ying Qin, Hui Song, Wei Zhao

×

Figure 5

SAT1 enhances 2′3′-cGAMP–induced STING activation.

Options: View larger image (or click on image) Download as PowerPoint
SAT1 enhances 2′3′-cGAMP–induced STING activation.
(A) IB analysis of ly...
(A) IB analysis of lysates from Sat1+/+ or Sat1–/– mouse PMs incubated with 2′3′-cGAMP–biotin for 4 hours, followed by IP with streptavidin. (B) IB analysis of STING dimerization in Sat1+/+ or Sat1–/– PMs stimulated by 2′3′-cGAMP. STING dimerization levels were quantitated by measuring dimer-STING band intensities using ImageJ software, and the values were normalized to actin (bar chart). (C) IB analysis of indicated proteins in Sat1+/+ or Sat1–/– mouse PMs, followed by 2′3′-cGAMP transfection. (D–F) ELISA analysis of cytokines secretion in Sat1+/+ or Sat1–/– PMs followed by CDN transfection (Trans.). (G and H) IB analysis of indicated proteins (G) or ELISA analysis of IFN-β secretion (H) in mouse PMs pretreated with 20 μM pentamidine for 24 hours, followed by 2′3′-cGAMP transfection. (I and J) ELISA analysis of IFN-β secretion (I) or IB analysis (J) in Sat1+/+ or Sat1–/– PMs pretreated with 10 μM DENSpm for 24 hours, followed by 2′3′-cGAMP stimulation. (K) qPCR analysis of interferon expression from Sat1+/+ MEFs transfected with an empty vector (Sat1+/+), Sat1–/– MEFs transfected with an empty vector (Sat1–/– +control [Ctrl]) or SAT1 plasmid (Sat1–/– +SAT1), followed by 2′3′-cGAMP transfection. (L–N) Sat1+/+ or Sat1–/– mice were injected i.p. with 2′3′-cGAMP (50 μg per mouse). The serum cytokines were analyzed using ELISA after 2′3′-cGAMP injection for 2 hours (L). Gene expression in liver and spleen were analyzed using qPCR after 2′3′-cGAMP injection for 8 hours (M and N) (US, unstimulated; n = 2; 2′3′-cGAMP, n = 8 per condition). Statistical significance was determined using an unpaired 2-sided t test, and adjustments were made for multiple comparisons in B, D–F, H, I, and K–N. The data are shown as the mean ± SEM. *P <0.05, **P <0.01. Similar results were obtained from 3 independent experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts